7.7 Haemoglobinopathies, Sickle Cell Disease and Thalassaemia
Key Takeaways
Interpret persistent microcytosis with iron studies, family history and appropriate haemoglobin analysis.
Recognise sickle cell fever, respiratory deterioration, sudden anaemia and new focal neurological signs as urgent presentations.
Coordinate disease modification, transfusion, iron monitoring and transition with the specialist team.
Distinguish a structural variant from reduced globin production
In sickle cell disease, haemoglobin S can polymerise when deoxygenated. The resulting change in red cells contributes to haemolysis and vaso-occlusion. Sickle cell disease includes HbSS and combinations such as HbSC or HbS with beta-thalassaemia. Sickle trait (HbAS) is a carrier state. If both biological parents have HbAS, each pregnancy has a 25% chance of HbSS and a 50% chance of HbAS. Offer appropriate testing and counselling. The Irish national newborn bloodspot panel effective from 11 November 2026 does not include sickle cell disease. Pursue assessment if clinical or family findings indicate it.
Thalassaemia reduces synthesis of an alpha- or beta-globin chain. A carrier can have microcytosis and relatively preserved haemoglobin, while clinically significant disease can cause anaemia, impaired growth and splenic enlargement. For persistent microcytosis, check full blood count, film, iron studies and the medical and family history. Iron deficiency can coexist. Use laboratory haemoglobin fractionation, such as high-performance liquid chromatography or capillary electrophoresis, for suspected haemoglobinopathy. Inform the laboratory about recent transfusions. Routine fractionation can miss alpha-thalassaemia trait, so discuss appropriate molecular investigation with haematology when suspicion persists.
HSE sickle cell disease · Irish newborn bloodspot procedure · NHLBI sickle cell diagnosis · TIF transfusion-dependent beta-thalassaemia, 5th edition.
Recognise an emergency in sickle cell disease
Assess vital signs, oxygen saturation, pain, circulation and neurological status. Ask what is different from usual, including baseline haemoglobin, regular treatment and the latest transfusion. Give prompt appropriate analgesia and reassess the response. Look for infection, acute chest syndrome, acute anaemia, stroke and other causes of the pain. Use the individual plan and contact haematology early when there are complications.
| Finding | What it suggests and what to do |
|---|---|
| Fever or systemic illness | Functional impairment of the spleen increases the risk of serious infection. Arrange urgent assessment. Obtain blood cultures if feasible without delaying indicated parenteral antibiotics. Follow the local sickle cell and sepsis pathway even when the initial examination looks reassuring. |
| New cough, chest pain, breathlessness or hypoxaemia | Consider acute chest syndrome. Respiratory symptoms and/or fever with a new pulmonary infiltrate support the diagnosis. It can evolve after admission for limb or back pain. Assess oxygenation, obtain chest imaging and involve haematology early. Give oxygen for hypoxaemia and appropriate antibiotics, analgesia and respiratory care. |
| Sudden pallor, increased spleen size and acute haemoglobin fall | Consider acute splenic sequestration, especially in a child. Check full blood count and reticulocytes and assess for shock. Coordinate resuscitation and a transfusion plan urgently. A marked reticulocyte fall suggests marrow suppression, including parvovirus B19-associated aplastic crisis. |
| New weakness, speech change or other focal deficit | Activate the emergency stroke pathway and involve haematology immediately. Assessment and imaging proceed alongside urgent decisions on sickle cell transfusion. |
Discuss early red-cell transfusion for hypoxic acute chest syndrome. The BSH and ASH guidance support escalation to exchange transfusion for severe or rapidly progressive disease, especially when a simple transfusion would be unsafe or has been insufficient. The exact choice depends on the severity, starting haemoglobin and specialist resources. Worsening respiratory status also requires urgent critical care assessment.
CHI paediatric sickle cell pain guideline · NHLBI acute complications · BSH acute chest syndrome · ASH transfusion guideline · ASH cerebrovascular guideline.
A child with HbSS was admitted for severe leg pain. Several hours later the child develops fever, tachypnoea, oxygen saturation of 89% on room air and a new pulmonary infiltrate. What is the best immediate response?
Continue treatment as an uncomplicated limb pain episode and recheck tomorrow
Treat this as acute chest syndrome, give oxygen for hypoxaemia and arrange urgent haematology-led treatment
Arrange outpatient transfusion review once the fever resolves
Treat presumed aplastic crisis alone and wait for the reticulocyte count before addressing breathing
Plan monitoring across childhood and adult care
Sickle cell follow-up combines a written emergency plan, immunisation and age-appropriate infection prophylaxis with specialist review for disease modification. Hydroxycarbamide can reduce recurrent vaso-occlusive episodes in eligible patients. Selected children undergo transcranial Doppler surveillance for stroke risk and may need a preventive transfusion programme. For example, ASH recommends annual screening from ages two to 16 for children with HbSS or HbS/beta-zero thalassaemia. Use the local team’s schedule and the individual care plan.
In transfusion-dependent beta-thalassaemia, regular specialist-led red-cell transfusions treat anaemia and suppress ineffective erythropoiesis. Repeated transfusions can cause iron overload. Follow serial ferritin and specialist assessment of liver and cardiac iron, often using MRI. Iron chelation and organ surveillance address the accumulation and its effects. Check growth, development, cardiac and endocrine health. Reproductive counselling applies to patients and carriers. Provide clear responsibility for prescriptions, transfusion appointments and emergency advice when young people move to adult care.
HPRA hydroxycarbamide information · ASH cerebrovascular guidance and teaching materials · TIF transfusion chapter · TIF monitoring recommendations · HSE transition framework.
A well adolescent has persistent microcytosis, iron studies that do not support iron deficiency and a parent with beta-thalassaemia trait. There is no recent transfusion. Which test is most useful next to investigate the suspected cause?
Serum vitamin B12 alone
Repeat a routine newborn bloodspot screen
Laboratory haemoglobin fractionation, with specialist interpretation and additional testing if needed
Use the red-cell count as proof of the diagnosis and avoid further testing
Sections you finish are checked off in the contents.